1. Chapter one – introduction
2. Chapter two – summary
3. Chapter three – market overview
3.1. Evolution of medical device technologies
3.2. Defining the top ten medical device technologies market
3.3. Patients' drift towards better quality of life leading to adoption of innovative medical devices
3.4. Aging population over 65 dictates the market for medical devices
3.5. Opportunity for medical device technologies lies in the less developed countries
3.6. Extensive product recalls is a major challenge for the medical device industry
4. Chapter four – diagnostic imaging
4.1. Market drivers
4.1.1. Emergence of new technology in diagnostic imaging
4.1.2. Expansion in the applications of diagnostic imaging
4.1.3. Aging demographics
4.1.4. Preventative healthcare in demand
4.1.5. Expansion of testing technologies coverage
4.2. Restraints
4.2.1. Slowdown in demand for medical imaging equipments due to economic turmoil
4.2.2. Regulatory body initiatives to tighten the healthcare cost are slowing the sales of these devices
4.3. Competitive landscape
4.4. Mri systems
4.4.1. Market drivers
4.4.1.1. Wide variety of application
4.4.1.2. Improvement in telsa strength
4.4.2. Competitive landscape
4.5. Ultrasound systems
4.5.1. Market drivers
4.5.1.1. Untapped demand of emerging market driving the growth of ultra sound system market
4.5.1.2. Refurbished equipment market for ultrasound system is booming
4.5.1.3. Increased use of ultrasound by emergency medical services and non-radiologists
4.5.2. Restraints
4.5.2.1. Saturation in core market limiting the sales for new ultrasound system
4.5.2.2. Lack of clear and adequate reimbursement for new ultrasound capabilities
4.5.3. Competitive landscape
4.6. X-ray systems
4.6.1. Market drivers
4.6.1.1. Finer image quality
4.6.2. Restraints
4.6.2.1. Other advanced diagnostic imaging technologies hindering the growth of x-ray market
4.6.2.2. Cost issues affecting the further spread of x-ray market
4.6.3. Competitive landscape
4.6.3.1. Merges and acquisitions for x-ray systems market
4.6.3.2. Other developments for x-ray systems
4.7. Mammography equipments
4.7.1. Market drivers
4.7.1.1. Increase in demand of digital mammography enhancing the growth opportunities for the mammography equipment due to advanced technology
4.7.1.2. Favorable reimbursement scenario boosting the demand for the mammography equipment
4.8. Tomography equipments
4.8.1. Market drivers
4.8.1.1. Introduction of higher slice ct scanner promising growth opportunities in the tomography market
4.8.1.2. Increase in angiogram ct application is driving the growth of the market
4.8.1.3. Optical coherence tomography (oct) is the new optics technology creating a significant niche in ophthalmology
4.8.2. Restraints
4.8.2.1. Shift from a slice count basis to detector coverage
4.8.2.2. Mri moving ahead from ct scan
4.8.3. Competitive development
4.9. Nuclear imaging equipments
4.9.1. Nuclear imaging getting widely accepted for early diagnosis of cardiology, cancer and neurological disorder
4.9.2. Hybrid imaging modalities capturing the nuclear imaging equipments market
4.9.3. Competitive landscape
4.9.4. Other developments
4.10. Interventional radiology
4.10.1. Market drivers
4.10.1.1. Advances in medical instrumentation and in radiological imaging technology are driving the market for interventional radiology procedures
4.10.1.2. Minimally invasive imaging procedures cardiac interventional and radiology vascular interventional radiology are gaining popularity
4.10.2. Restraints
4.10.2.1. Financial limitation put a stop to capital investment by the hospitals for interventional radiology
4.10.2.2. Lack of professional radiologist affecting the interventional radiology market
4.10.3. Competitive landscape
4.11. Capsule endoscopy
4.11.1. Market drivers
4.11.1.1. Application of capsule endoscopy for gastrointestinal ailments diagnosis is picking up due to innovative design for colonic indications
4.11.1.2. Favorable move from fda further clearing the growth path for capsule endoscopy
4.11.2. Competitive landscape
4.12. Lasers – imaging
4.12.1. Market drivers
4.12.1.1. Reasonably priced lasers has marked its presence in medical fraternity
4.12.1.2. A number of benefits expand the scope and opportunities for the laser technology
5. Chapter five – Drug delivery devices
5.1. Inhalation systems
5.1.1. Market drivers
5.1.2. Competitive landscape
5.2. Infusion system
5.2.1. Competitive landscape
5.3. Needle-free injection/transdermal systems
5.3.1. Market drivers
5.3.2. Restraints
5.3.3. Competitive landscape
6. Chapter six – Medical diagnostics
6.1. Market drivers
6.1.1. Popularity of point of care (poc) and home health care driving the market for medical diagnostic
6.1.2. The medical diagnostic is expected to expand due to rise in demand for genetic testing, esoteric testing and high end molecular diagnostic testing
6.2. Restraints
6.2.1. Factors such as economic slowdown, drugs abuse testing, test validation has affected the market momentum as confusion prevails among common public
6.3. Biosensors
6.3.1. Market drivers
6.3.1.1. Increase in biosensor usage due to multiple applications leading to market growth of biosensors
6.3.1.2. Population explosion and unhealthy lifestyles leading to the explosive demand for biosensors
6.3.1.3. Miniaturization key to success for biosensors
6.3.2. Restraints
6.3.2.1. High cost involved in r&d of biosensors
6.4. In vitro diagnostic (ivd)
6.4.1. Market drivers
6.4.1.1. Demand for the ivd in emerging markets
6.4.1.2. Increase in worldwide aging population needing diagnostic services
6.4.1.3. Increase in accessibility health care services by people
6.4.2. Restraints
6.4.2.1. Consolidation of hospital and commercial laboratories market and price pressure affecting the market growth
6.4.2.2. Intense scrutiny by food and drug authority (fda) on ivd diagnostic market restraining the market
6.5. Proteomics for molecular diagnostics
6.5.1. Market drivers
6.5.1.1. Proteomics: serving an opportunity for new drug and diagnostic market in terms of targeting more diseases
6.5.1.2. Proteomics is a tool for analysis of pharmacological profiling, toxicity testing and drug’s effectiveness
6.5.1.3. Enables detection of non communicable diseases
6.5.2. Restraints
6.5.2.1. The structuring of proteins needs expensive tools and machines leading to lower adoption rates
6.5.2.2. Cost & reimbursement complexities emerging as major obstacles for the market
6.5.2.3. Lack of technologies to speed up validation process
6.5.3. Competitive landscape
6.5.3.1. New product launch
6.6. Nanotechnology for molecular diagnostics
6.6.1. Market drivers
6.6.1.1. Increase in demand of genetic screening, preimplantation screening and for the diagnosis of infectious diseases
6.6.2. Opportunity
6.6.2.1. Nanotechnology for cancer diagnostics showcasing promising future
6.6.3. Restraint
6.6.3.1. Lack of commercialization of nanotechnology medical devices
6.6.4. Competitive landscape
6.6.4.1. New product launch
6.6.4.2. Other developments
6.7. Pcr (polymerase chain reaction)
6.7.1. Market drivers
6.7.1.1. Potential to replace the conventional tests for infectious diseases, cancer diagnosis and genetic diseases
6.7.1.2. Real- time pcr instrumentation clearance from fda is strengthening the clinical diagnostic market
6.7.2. Restraint
6.7.2.1. New technology, qpcr is replacing conventional pcr market
6.7.2.2. Price sensitivity of pcr technology is area of concern for the end users
6.8. Arrays
6.8.1. Market drivers
6.8.1.1. Demand for protein array on rise as it is facilitating drug discovery
6.8.1.2. Classification of cancers done by micro array technology helping doctors to give appropriate treatment to the patients
6.8.1.3. Minimal use of materials makes microarrays an inexpensive technology
7. Chapter seven – mobility aid technologies
7.1. Market drivers
7.1.1. Aging population with mobility issues driving the market for mobility aid technology
7.1.2. Demand for more independent life and assistance free daily living
7.1.3. Popularization of physically challenged sports and recreation program
7.1.4. Emergence of robotics technology in assistive device market
7.2. Restraints
7.2.1. Manual wheel chairs not suitable for people who suffer impairment of upper limbs
7.3. Competitive landscape
7.4. Global mobility aid technologies market by product types
7.4.1. Wheelchairs and related devices
7.4.1.1. Market drivers
7.4.1.1.1. Rise in population suffering from arthritis, arthrogryposis, osteoporosis etc.
7.4.1.1.2. Wide range of designs, materials, and configurations available in the market attracts users looking for the comfort
7.4.1.1.3. Increase in demand for power wheel chair because of more efficient mobility
7.4.1.2. Restraints
7.4.1.2.1. Power dependence by powered wheel chair
7.4.1.2.2. Powered assist device more costly and less portable then manual wheel chair
7.4.1.2.3. Reimbursement issues with the powered wheelchairs
7.4.1.3. Competitive landscape
7.4.1.4. Manual wheelchairs
7.5. Global mobility aid device market by technology
7.5.1. Robotics
7.5.2. Non robotics
7.5.3. Walking-assist devices
7.5.3.1. Market drivers
7.5.3.1.1. Changes in social trends like single parent and small family size creating demand for walking assist devices
7.5.3.1.2. More cases of cerebral palsy leading demand for more walking assist device to improve quality life
7.5.3.2. Restraints
8. Chapter eight – minimal invasive/non invasive surgery
8.1. Market drivers
8.1.1. Increase in aging population (65+) boosts the demand for surgeries
8.1.2. Increase in demand of less risky operating methods
8.1.3. Pressure to reduce heath care cost increases the market for minimal invasive surgery
8.1.4. Lesser hospitalization period compared to conventional surgeries
8.1.5. Higher rate of acceptance of minimal invasive surgery techniques
8.1.6. Less painful and quicker recovery method of surgery compared open surgeries
8.2. Restraints
8.2.1. Limited number of surgeries performed with minimal invasive technique
8.2.2. Special training and equipment is required to perform minimal invasive surgery
8.3. Opportunities
8.3.1. Huge market size attracting new entrants in minimal invasive market
8.3.2. Physicians are setting a strong foundation for the future of minimal invasive surgery market
8.4. Stent
8.4.1. Market drivers
8.4.1.1. Rise in cardio vascular diseases and access to conventional as well as hybrid cardiovascular procedures
8.4.1.2. Rise in demand of minimal invasive heart surgeries
8.4.1.3. Increase in number of obese and diabetic population world wide
8.5. Medical robotics
8.5.1. Market drivers
8.5.1.1. Improved surgical results attracting more patients
8.5.1.2. Shortening of surgical time is increasing the revenue of hospitals
8.5.1.3. Improved surgeon ergonomics brings in accuracy
8.5.1.4. Cost effectiveness
8.5.2. Restraints
8.5.2.1. Lack of human touch and intelligence
8.5.3. Competitive landscape
8.6. Light amplification by stimulated emission of radiation (lasers)
8.6.1. Market drivers
8.6.1.1. Growing awareness among people about laser technology has led to increased acceptance
8.6.1.2. Rise in age-related diseases likely to enhance sales
8.6.2. Developments
8.7. Bariartic surgery
8.7.1. Market drivers
8.7.1.1. Growing number of overweight and obese population has increased the demand for surgeries
8.7.1.2. Technological innovation with better and faster patient outcomes attracts patients
8.7.1.3. Rising obesity among children expands the patient base
8.7.1.4. Increase in awareness of obesity as a dangerous disease
9. Chapter nine – micro- fluids chip and mems
9.1. Market drivers
9.1.1. Cost effective complex analysis system can be developed on a microfluidic (mf) chip
9.1.2. Mf chip acts as an essential tool for mass spectrometry
9.1.3. Complete automation in a single device leads to reduction in accidental loss of reagents
9.1.4. Microchips enable greater speed & higher quality of output
9.1.5. The minimal requirement of samples results in cost reduction
9.2. Restraints
9.2.1. Microfluidic chip technology unable to mix fluids on the chips in an effective manner, making them less favorable for analysis of complex fluids
9.2.2. Lack of commercialization with respect to mems technology
9.3. Miniature medical pressure sensors
9.4. Biochips
9.4.1. Market drivers
9.4.2. Restraints
9.4.3. Competitive landscape
9.4.3.1. Other developments
9.5. Dna chips
9.5.1. Advances in microfluidics has strengthen the commercial potential of loc
9.5.2. The demand for reduced sample size and reagent cost for new drug discovery has been major targeted areas of loc
9.5.3. High development cost hampers the penetration of loc market
9.6. Protein chips
9.6.1. Competitive landscape
9.6.1.1. Mergers and acquisitions for protein chips
9.6.1.2. Other developments for protein chips
10. Chapter ten – Non invasive monitoring
10.1. Biosensors
10.1.1. Wide scale acceptability of biosensors leading to deep penetration in the diagnostic market
10.1.2. High cost involved in wide scale commercialization of biosensors restraining the growth of the market
10.1.3. Continuous glucose monitoring
10.1.3.1. Market drivers
10.1.3.1.1. Emergence of diabetes as an epidemic worldwide has spurt the demand for continuous glucose monitoring
10.1.3.1.2. Convenient usage of non invasive continuous glucose monitoring facilitating the market growth of continuous glucose monitoring
11. Chapter eleven – Biomaterials
11.1. Increase in aging population with a surge in age related orthopedic conditions will increase the demand for biomaterials
11.2. Cost- containment strategy and high degree of regulatory scrutiny by government is affecting the european and u.s. Market
11.3. Applications of biomaterials
11.4. Bionic limbs
11.5. Competitive landscape
11.6. Bio-compatible materials
11.6.1. Market drivers
11.6.1.1. Advancements in nanotechnology will boost the performance of bio-compatible ceramics
11.6.1.2. Increase in demand of bio-compatible materials due to older population and demand from young people for highly functional requirements
11.6.2. Vulcanized silicon based materials
11.6.3. Joint replacement
11.6.3.1. Market drivers
11.6.3.1.1. Rise in prevalence and incidences of orthopedic diseases in aging population
11.6.3.1.2. Rise in the level of acceptability of bone grafts substitutes in wide range of application
11.6.3.2. Restraints
11.6.3.2.1. Rise in prices of titanium restraining the joint replacement market
11.6.3.2.2. Modification in reimbursement policies affecting the joint replacement surgeries will affect the components used in joint replacement as well as surgeries
11.7. Antimicrobial wound dressing
11.7.1. Market drivers
11.7.1.1. New products in anti microbial wound dressing are driving the growth potential of this market
11.7.1.2. Active demand of anti microbial wound dressing in the home health care
11.7.2. Restraints
11.7.2.1. Reluctance on part of physicians and nurses to adopt new products such that antimicrobial wound dressing
12. Chapter twelve – Bio-implants
12.1. Graft based implants
12.1.1. Market drivers
12.1.1.1. An increase in acceptance of graft based implants by medical practitioners
12.1.1.2. Cosmetic surgery is gearing up due to the desire of beautiful personality
12.1.2. Restraints
12.1.2.1. Expensive bone grafts
12.1.2.2. Less interest shown by doctors to adopt new technique like bone graft
12.2. Synthetic implants
12.2.1. Market drivers
12.2.1.1. Wide area of applications are driving the market of synthetic implants
12.2.1.2. Good bio-compatibility of synthetic implants is making them a safe choice for implants
12.2.2. Competitive landscape
12.2.3. Neurostimulation
12.2.3.1. Market drivers
12.2.3.1.1. Rise in the aging population above 60+ (age) boosts the demand for neurostimulation market